Business · 16/10/2026
Myosin Therapeutics Invited to Present at BioFuture 2026 in New York City
Myosin Therapeutics has been invited to present at BioFuture 2026 in New York City, following its selection as a 2026–2027 National Cancer Institute SBIR Investor Initiatives Showcase Company.